FindTrial
Sign In

Comparison of everolimus eluing stent and zorarolimus eluting stent in long coronary artery lesion

Comparative registry of everolimus eluting stent and zotarolimus eluting stent in diffuse long coronary artery lesion(EXLONG registry) ; A multicenter, cohort observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0000208
Enrollment
600
Registered
2011-10-26
Start date
2011-11-01
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Pusan National University Yangsan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Among patient with long coronary artery lesions(25mm), patient who underwent PCI with everolimus eluting stents or zotarolimus eluting stent, total length of which is over 25mm. 2. Patients who signed informed conscent form of this study

Exclusion criteria

Exclusion criteria: 1. Patients who underwent PCI with different kinds of stents 2. In case that the edges of stents are separated when 2 or more stents were used 3. Patietnts whose life-expectancy is less than 1 year 4. Paients with cardiogenic shock

Design outcomes

Primary

MeasureTime frame
Target lesion failure(cardiac death, target vessel MI, clinically driven TLR)—

Secondary

MeasureTime frame
all-cause death;cardiac death;Myocardial infarction;target vessel revascularization;target lesion revascularization;Stent thrombosis;success of PCI—

Countries

Korea, Republic of

Contacts

Public ContactSanh-eun Lee

Pusan National University Yangsan Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026